banner

Nezvedu

Profile yekambani

Innovita Biological Technology Co., Ltd. (pamwe chete nemakambani ayo, pamwe chete anozivikanwa se "INNOVITA",) ikambani yebiotechnology inotarisana nekutsvaga, kusimudzira, kugadzira uye kutengesa kwe in vitro diagnostic POCT zvigadzirwa. Inosanganisira Innovita (Tangshan) , Innovita (Beijing) uye Innovita (Guangzhou).

● Yakatangwa muna 2006

● Gadzira nzvimbo dzeR&D muBeijing neGuangzhou, nenzvimbo yekugadzira muQian'an, Hebei.

about-us (3)
about-us (23)

Profile yekambani

Yakatangwa muna 2006, INNOVITA yakavaka mapuratifomu matanhatu ehunyanzvi akadai seantigen & antibody kugadzirira, hutachiona tsika, colloidal goridhe, ELISA, fluorescence chromatography, immunofluorescence, uye inoita Chinese National High-tech R&D Chirongwa mundima yenyika huru yezvirwere zvinotapukira uye zvakawanda. zvimwe zvirongwa zvehutano hweveruzhinji.Kunze kwezvo, INNOVITA ine pamusoro pegumi patents yenyika uye inomisikidza Beijing R&D Center, Guangzhou R&D Center, Hebei yekugadzira base.Nemashopu makuru akachena, uye kumisikidza colloidal goridhe, ELISA, fluorescence chromatography, PCR, immunofluorescence kugadzira mitsara, INNOVITA yakawana CE uye ISO13485 chitupa.

Parizvino, zvigadzirwa zveINNOVITA zvine bvunzo dzekufema, bvunzo dzekubereka, hepatitis bvunzo, TORCH bvunzo, yemoyo bvunzo, renal basa bvunzo uye zvichingodaro.Network yekutengesa yakafukidza matunhu ese nematunhu muChina, uye yakapararira kuSoutheast Asia, Middle East, Africa, Latin America, European Union nemamwe matunhu ekunze.INNOVITA inoomerera kune mutengi-centric bhizinesi uzivi, uye inoshandira vatengi neyakajeka uye iri nyore zvigadzirwa.Zvinodiwa nevatengi ndiko kutsvaga kweINNOVITA.

Development Process

  • Muna 2006
    ● Yakavambwa Beijing R&D centre.
  • Muna 2011
    ● Yakagadzira nzvimbo dzekugadzira Tangshan.
  • Muna 2014
    ● ISO 13485 yakasimbiswa.
  • Muna 2018
    ● Strategic investment by Genesis Capital.
    ● Yakatanga kudyidzana nedzimwe nyika.
  • Muna 2019
    ● Strategic investment neSequoia Capital.
  • Muna 2020
    ● Yekutanga NMPA yakatenderwa COVID-19 IgM/IgG Combo Test.
    ● Kutengeswa kunze kwenyika dzinopfuura 70/nzvimbo.
    ● Yakapihwa Advanced Collective muNational Commendation Congress yeKurwisa COVID-19 Pandemic.
    ● COVID-19 IgM/IgG bvunzo yakawana Emergency Use Authorization (EUA) neUS FDA.
  • Muna 2022
    ● Kutanga kutanga musangano paSSE STAR Market, uye ichanyorwa paChina Sci-Tech Innovation Board munguva pfupi.
  • Mapazi

    about-us (7)

    Beijing R&D & Marketing Center

    Kuvambwa:2006

    Tarisa:R&D, kugadzira, kushambadzira kwe-in-vitro diagnostic chigadzirwa, kusanganisira mapuratifomu akadai se immunodiagnosis, molecular diagnosis, uye gene machipisi.

    Qian'an Manufacturing & Logistic Center

    Kuvambwa:2011

    Nzvimbo:Kuvhara nzvimbo yemaeka zana nemakumi mashanu, yakatenderedza zviuru zvisere ㎡ nzvimbo yemusangano, yakashongedzerwa nemitsara yakawanda yekugadzira yegoridhe colloidal, ELISA, PCR.

    Certification:ISO 13485, CE, FDA, NMPA, nezvimwe.

    Guangzhou R&D Center

    Kuvambwa:2020

    Tarisa:R&D yeIVD tekinoroji

    Platforms

    plate

    Marketing Network

    Mushure memakore ebudiriro, Innovita yatove neyakazara yekutengesa uye sevhisi network, ine nzira dzekutengesa dzinofukidza matunhu makumi matatu nemaviri nematunhu muChina, uye yakatumira kune misika yepasi rose seSoutheast Asia, Middle East, Africa, Latin America, Europe, nezvimwe.

    Innovita 2019-nCoV Ab Test inoratidzwa papuratifomu yenyika yechimbichimbi yemishonga nemidziyo yekurapa

    Musi waKukadzi 28, 2020, Mutungamiriri Li Keqiang akaongorora chikuva chepasirese chemishonga nemidziyo yekurapa yeCCIDID-19.Innovita 2019-nCoV Ab Test yakaratidzwa seyekutanga NMPA yakatenderwa IgM/IgG combo antibody bvunzo, iyo yakashumwa paCCTV.

    about-us (26)
    about-us (11)

    Innovita 2019-nCoV Ab Test yakatumidzwa naAcademician Zhong Nanshan

    ● Masikati aFebruary 23, 2020, Academician Zhong Nanshan akaburitsa pachena panguva yekubvunzana kure muGuangzhou nechikwata chekurapa cheGuangdong vachimhanyidzana kubatsira Jingzhou kuti National Medical Products Administration yakabvumidza maviri matsva ebvunzo e2019-nCoV, imwe yacho iri. yakagadzirwa neInnovita (Tangshan) Biological Technology Co., Ltd.

    ● Kiti inoshandisa nzira yegoridhe inonzi colloidal, inogona kuona masoja ekudzivirira chirwere anonzi lgM mumuviri womurwere.Iyo lgM masoja ekudzivirira chirwere anogona kuonekwa pazuva rechinomwe rechirwere chemurwere kana kuti zuva rechitatu rekutanga, izvo zvinobatsira zvikuru kuti murwere awedzere kuongororwa.Zhong Nanshan akati: "Varwere vanogona kukurumidza kuzivikanwa kuti vaongororwe zvakanaka. Izvi zvinogona kutibatsira kukurumidza kuparadzanisa vanhuwo zvavo kubva kune vane hutachiona."

    about-us (15)

    Advanced Collective Award

    about-us (8)

    Kurwisa Pandemic

    Combating Pandemic